Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation-Reference-Cited by-同舟云学术

Epstein-Barr Virus Latent Infection and BAFF Expression in B Cells in the Multiple Sclerosis Brain: Implications for Viral Persistence and Intrathecal B-Cell Activation

Published:2010-07 Issue:7 Volume:69 Page:677-693
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:J Neuropathol Exp Neurol

Author:

Serafini Barbara,Severa Martina,Columba-Cabezas Sandra,Rosicarelli Barbara,Veroni Caterina,Chiappetta Giuseppe,Magliozzi Roberta,Reynolds Richard,Coccia Eliana Marina,Aloisi Francesca

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Neurology,General Medicine,Pathology and Forensic Medicine

Reference83 articles.

1. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

2. Environmental factors and multiple sclerosis

3. Multiple sclerosis

4. Environmental risk factors for multiple sclerosis;Ascherio;Part I: The role of infection. Ann Neurol,2007

5. EBV in MS: guilty by association?

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T-cells in multiple sclerosis are activated by Epstein-Barr Virus and produce IL-10 in the central nervous system;2024-07-30

2. EBV and multiple sclerosis: expression of LMP2A in MS patients;Frontiers in Neuroscience;2024-04-24

3. EBV infected cells in the multiple sclerosis brain express PD-L1: How the virus and its niche may escape immune surveillance;Journal of Neuroimmunology;2024-04

4. Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity;Journal of Neuroimmunology;2024-02

5. B cell activating factor levels are linked to distinct B cell markers in multiple sclerosis and following B cell depletion and repopulation;Clinical Immunology;2024-01